HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Calcium dobesilate in patients suffering from chronic venous insufficiency: a double-blind, placebo-controlled, clinical trial.

AbstractOBJECTIVE:
To test the efficacy of calcium dobesilate (CaD) in chronic venous insufficiency (CVI).
METHOD:
Double-blind, parallel groups, placebo-controlled, multicentre trial in adult patients with symptomatic CVI and pitting oedema. Wearing of compression stockings Class II was admitted. During treatment period of eight weeks, the patients received CaD 3 × 500 mg/day or placebo. The leg volume calculation was based on a truncated cone model.
RESULTS:
A total of 256 patients was randomized to treatment (dobesilate: n = 132, placebo: n = 124); the demographic and anamnestic data at admission were comparable in the two therapeutic groups. The volume of the lower calf diminished in the dobesilate group at the end of the active treatment period by -64.72 ± 111.93 cm³ (mean ± SD), independent of the concomitant usage of compression stockings versus placebo +0.8 ± 152.98 cm³ (P = 0.0002). The symptoms of pain, discomfort, heavy legs, tired legs, tingling, itching and cramps, as well as the global assessments by investigators and patients, also improved significantly (P < 0.05) better in the dobesilate group at the end of the treatment. The observed adverse events correspond to the known profile.
CONCLUSION:
Dobesilate reduces leg oedema and improves the symptoms of objectively diagnosed CVI, independent of the concomitant usage of compression stockings.
AuthorsE Rabe, K A Jaeger, M Bulitta, F Pannier
JournalPhlebology (Phlebology) Vol. 26 Issue 4 Pg. 162-8 (Jun 2011) ISSN: 1758-1125 [Electronic] England
PMID21478142 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Hemostatics
  • Calcium Dobesilate
Topics
  • Adult
  • Aged
  • Calcium Dobesilate (administration & dosage)
  • Chronic Disease
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Hemostatics (administration & dosage)
  • Humans
  • Male
  • Middle Aged
  • Venous Insufficiency (drug therapy, pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: